Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥6,821,398 | CN¥6,863,773 | CN¥7,120,399 | CN¥6,999,423 |
| Short-Term Investments | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Receivables | CN¥1,807,435 | CN¥1,788,722 | CN¥1,707,816 | CN¥2,072,918 |
| Inventory | CN¥4,059,945 | CN¥4,241,184 | CN¥4,665,160 | CN¥4,544,935 |
| Other Curr. Assets | CN¥154,218 | CN¥145,299 | CN¥188,208 | CN¥180,561 |
| Total Curr. Assets | CN¥13,074,336 | CN¥13,193,621 | CN¥13,875,476 | CN¥14,003,269 |
| Property Plant & Equip (Net) | CN¥9,904,301 | CN¥11,816,214 | CN¥9,960,842 | CN¥9,951,912 |
| Goodwill | CN¥1,838,406 | CN¥1,838,406 | CN¥1,838,406 | CN¥1,838,406 |
| Intangibles | CN¥2,887,172 | CN¥1,030,966 | CN¥2,834,369 | CN¥2,562,149 |
| Long-Term Investments | CN¥1,004,272 | CN¥819,462 | CN¥0 | CN¥0 |
| Tax Assets | CN¥135,417 | CN¥140,832 | CN¥127,990 | CN¥127,226 |
| Other NC Assets | CN¥450,089 | CN¥383,818 | CN¥1,207,867 | CN¥1,166,772 |
| Total NC Assets | CN¥16,219,657 | CN¥16,029,698 | CN¥15,969,473 | CN¥15,646,465 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥29,293,993 | CN¥29,223,318 | CN¥29,844,949 | CN¥29,649,735 |
| Liabilities | – | – | – | – |
| Payables | CN¥983,531 | CN¥1,225,226 | CN¥1,369,770 | CN¥2,107,643 |
| Short-Term Debt | CN¥2,986,441 | CN¥2,341,044 | CN¥2,517,829 | CN¥2,353,237 |
| Tax Payable | CN¥0 | CN¥62,789 | CN¥55,435 | CN¥34,933 |
| Deferred Revenue | CN¥149,419 | CN¥0 | CN¥0 | CN¥0 |
| Other Curr. Liab. | CN¥38,042 | CN¥562,943 | CN¥902,226 | CN¥801,530 |
| Total Curr. Liab. | CN¥4,264,610 | CN¥4,266,751 | CN¥4,923,064 | CN¥5,374,509 |
| LT Debt | CN¥5,932,462 | CN¥5,881,626 | CN¥5,865,238 | CN¥4,936,094 |
| Deferred Rev, NC | CN¥127,362 | CN¥128,296 | CN¥129,231 | CN¥130,166 |
| Deferred Tax Liab, NC | CN¥190,150 | CN¥190,210 | CN¥188,917 | CN¥187,923 |
| Other NC Liab. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total NC Liab. | CN¥6,263,868 | CN¥6,215,966 | CN¥6,196,525 | CN¥5,268,708 |
| Other Liabilities | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥0 | CN¥15,834 | CN¥13,140 | CN¥14,525 |
| Total Liabilities | CN¥10,528,478 | CN¥10,482,717 | CN¥11,119,589 | CN¥10,643,216 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥8,831,391 | CN¥8,831,365 | CN¥8,831,250 | CN¥8,831,250 |
| Retained Earnings | CN¥9,575,076 | CN¥9,533,079 | CN¥9,490,177 | CN¥9,477,660 |
| AOCI | CN¥1,905,985 | CN¥993,140 | CN¥1,937,317 | CN¥0 |
| Other Equity | CN¥0 | CN¥0 | CN¥0 | CN¥1,138,549 |
| Total Equity | CN¥18,522,696 | CN¥18,491,495 | CN¥18,468,988 | CN¥18,626,392 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥242,819 | CN¥249,106 | CN¥256,372 | CN¥380,126 |
| Total Liab. & Tot. Equity | CN¥29,293,993 | CN¥29,223,318 | CN¥29,844,949 | CN¥29,649,735 |
| Net Debt | CN¥2,097,505 | CN¥1,358,897 | CN¥1,262,668 | CN¥289,909 |